Samuel Jourdan

Title: Samuel Jourdan: Innovator in DNA Aptamers

Introduction

Samuel Jourdan is a notable inventor based in Aubange-Battincourt, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of DNA aptamers. His work focuses on creating specific nucleic acid sequences that can bind to adenoviruses, which are important in various medical and research applications.

Latest Patents

Samuel Jourdan holds 1 patent for his invention titled "DNA aptamers specific of adenovirus types." This patent describes a single-stranded nucleic acid aptamer that can specifically bind to at least one adenovirus type. The aptamer comprises or consists of one of the sequences SEQ ID NO:1 to 3, or variants thereof having at least 50% sequence identity. Additionally, the patent includes a composition comprising the aptamer, as well as methods for detecting, capturing, concentrating, and quantifying adenovirus types. Furthermore, it outlines a kit designed for these purposes.

Career Highlights

Throughout his career, Samuel Jourdan has worked with esteemed institutions, including the Luxembourg Institute of Science and Technology. His research has contributed to advancements in the detection and quantification of adenoviruses, which are crucial for public health and safety.

Collaborations

Samuel has collaborated with notable colleagues such as Leslie Ogorzaly and Catherine Mulholland. Their combined expertise has furthered the development of innovative solutions in the field of biotechnology.

Conclusion

Samuel Jourdan's work in developing DNA aptamers represents a significant advancement in biotechnology. His contributions are vital for improving methods of detecting and quantifying adenoviruses, showcasing the importance of innovation in health-related research.